In vitro and in vivo experiments showed that it significantly down regulated the expression of Keap1, ACSL4 and FTL, and increased the levels of Nrf2, HO-1 and GPX4 in MI mice and OGD injured H9c2 cardiomyocytes. This evidence concerns the gene NFE2L2 and myocardial infarction.